We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI Model Helps Clinicians Detect Severe Coronary Artery Disease in Stress Echocardiograms

By HospiMedica International staff writers
Posted on 20 Dec 2021
Print article
Image: EchoGo (Photo courtesy of Ultromics Limited)
Image: EchoGo (Photo courtesy of Ultromics Limited)

A breakthrough study has shown that artificial intelligence (AI) is capable of independently reading stress echocardiograms and predicting coronary artery disease (CAD), significantly increasing detection compared to traditional methods.

The new study found that Ultromics Limited’s (Oxford, UK) AI-powered EchoGo platform significantly improved the accuracy and confidence in CAD detection from a stress echocardiogram. The study revealed that doctors are more confident in CAD diagnoses with the support of EchoGo. Further, the study revealed that the EchoGo AI improved the sensitivity of detection of the disease by over 10%, which brings the effectiveness of stress echocardiography - as a modality - on par with much more expensive and invasive diagnostic procedures.

Ultromics has developed an AI algorithm that automatically analyzes stress echocardiograms and tells the clinician whether that patient is at risk of coronary artery disease. The study assessed Ultromics’ deep learning algorithms trained on hundreds of thousands of data to predict CAD risk, and was able to distinguish the CAD risk in patients with 10% more sensitivity than manual analysis. During the first portion of the study, Ultromics AI was trained and tested to identify patients with severe coronary artery disease. Patients without CAD were correctly identified by AI 92.7% of the time and patients with CAD were correctly identified 84.4% of the time. The result showed a 10% increase in accuracy compared to the human eye.

The second part of the study sought to explore how an AI classification might impact physicians’ and echocardiographers’ clinical interpretation of stress echocardiograms. Four physicians/echocardiographers tested Ultromics’ AI and were asked to review heart ultrasounds to determine whether patients had CAD. Each physician / echocardiographer was shown each heart ultrasound two times, one month apart – once with the AI’s decision and once without – and were asked to determine whether they were confident in their clinical interpretation. When provided with the AI-generated classifications, the level of agreement between all four physicians/echocardiographers increased 15% or more - from between 68% and 79% accuracy, to between 83% and 97% accuracy.

“Using AI to make CAD predictions is a real breakthrough for science, it will help spot earlier signs of a problem, prevent unnecessary tests and procedures, and help save more lives”. said Dr. Ross Upton, a study author and the CEO and co-founder of Ultromics. “Traditionally, CAD analysis is done through manual observations. However, the complexity of identifying subtle features within an image means that it is not always easy to correctly identify CAD on first visit, and accurate diagnoses can be subject to the operator’s expertise. This means heart disease, the number one global killer, gets missed one in five times. With the support of our AI service, clinicians can make confident diagnoses and spot features which would have been impossible to detect using traditional methods.”

“Echocardiography is such a critical modality for diagnosing cardiovascular disease”, added Professor Paul Leeson, Professor of Cardiovascular Medicine at the University of Oxford and the co-founder of Ultromics. “It is affordable, accessible, portable, comfortable, non-invasive, and doesn’t emit radiation. The fact that we can now apply artificial intelligence to echocardiography to perform at this level is truly revolutionary for patient care.”

Related Links:
Ultromics Limited 


Print article

Channels

Critical Care

view channel
Image: Triage Cardiac Panel is a rapid, POC fluorescence immunoassay used with Triage MeterPro (Photo courtesy of Quidel)

Quidel Triage Cardiac Panel Facilitates Rapid POC Diagnosis of Chest Pain Patients in ED

Chest and abdominal pain are the most common reasons that persons aged 15 years and over visit the emergency department (ED). Because both emergency and non-emergency care are provided, symptoms vary widely... Read more

Surgical Techniques

view channel
Image: Resolute Onyx DES helps address all DES needs and numerous patient anatomies (Photo courtesy of Medtronic)

Medtronic’s Latest Generation Drug-Eluting Coronary Stent System Offers Dual-Layer Balloon Technology

Coronary artery disease (CAD) is one of the leading causes of death and is caused by plaque buildup on the inside of the coronary arteries. These plaque deposits can narrow or clog the inside of the arteries,... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.